These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9516363)

  • 21. [Treatment and prevention of hepatitis C].
    Poynard T; Ratziu V; Benhamou Y; Regimbeau C
    Rev Prat; 2000 May; 50(10):1100-7. PubMed ID: 10905096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Should hepatitis C be treated?].
    Tran A
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S148-53. PubMed ID: 9161526
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interferon-alpha and liver fibrosis in patients with chronic damage due to hepatitis C virus].
    Gonzalez-Huezo MS; Gallegos-Orozco JF
    Rev Gastroenterol Mex; 2003; 68(3):239-44. PubMed ID: 14702938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon: benefit beyond hepatitis therapy?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis C: natural history, biology, treatment monitoring].
    Poynard T
    Pathol Biol (Paris); 1999 Nov; 47(9):911-6. PubMed ID: 10609271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James.
    Dieterich D
    AIDS Treat News; 1998 May; (No 295):1-5. PubMed ID: 11365406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaesthesia for a patient on interferon therapy.
    Coleman M; Traynor C
    Acta Anaesthesiol Scand; 1999 Jan; 43(1):115-6. PubMed ID: 9926203
    [No Abstract]   [Full Text] [Related]  

  • 28. [Membranous nephropathy and hepatitis C virus infection].
    Egea JJ; Rivera F; Arenas MD; Olivares J
    Nefrologia; 2001; 21(4):411-2. PubMed ID: 11816520
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis C: screening and treatment].
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S202-11. PubMed ID: 9161531
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis C: screening and treatment].
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S213-6. PubMed ID: 9161532
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C: treatment challenges.
    Copley L
    Prof Nurse; 2003 Nov; 19(3):133-4. PubMed ID: 14639900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.
    Di Martino V; Thevenot T; Colin JF; Boyer N; Martinot M; Degos F; Coulaud JP; Vilde JL; Vachon F; Degott C; Valla D; Marcellin P
    Gastroenterology; 2002 Dec; 123(6):1812-22. PubMed ID: 12454838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidermolysis bullosa acquisita and hepatitis C].
    Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
    Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
    Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hepatitis C--update 2005].
    Forestier N; Zeuzem S
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S215-6. PubMed ID: 16435713
    [No Abstract]   [Full Text] [Related]  

  • 38. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.